Crossmark

The effect of combination therapy on Bevacizumab, Carmustine, and Metformin chemotherapy drugs on the fluctuating performance expression of TLR2, TLR6, and IL-6 genes in the cell line of brain glioblastoma

Crossref DOI link: https://doi.org/10.1186/s12935-025-04033-0

Published Online: 2025-11-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Norollahi, Seyedeh Elham

Yousefi, Bahman

Yousefzadeh-Chabok, Shahrokh

Nejatifar, Fatemeh

Samadian, Mohammad

Evazalipour, Mehdi

Eftekhary, Mohamad

Akhlaghi, Masoud Faghih

Mirzajani, Ebrahim

Rashidy-pour, Ali

Samadani, Ali Akbar
License Information

Text and Data Mining valid from 2025-11-12

Version of Record valid from 2025-11-12
More Information

Article History

Received: 15 April 2025

Accepted: 14 October 2025

First Online: 12 November 2025

Declarations

:

: Ethics code: IR.SEMUMS.REC.1402.035 and consent to participate: Agreed.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below